Sana biotechnology to present at the 32nd annual oppenheimer healthcare conference

Seattle, march 09, 2022 (globe newswire) -- sana biotechnology, inc. (nasdaq: sana), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast its presentation at the 32nd annual oppenheimer healthcare conference at 6:20 a.m. pt on wednesday, march 16, 2022. the presentation will feature a business overview and update by steve harr, sana's president and chief executive officer.
SANA Ratings Summary
SANA Quant Ranking